Long‐term outcome of juvenile idiopathic arthritis following a placebo‐controlled trial: sustained benefits of early sulfasalazine treatment

OBJECTIVES: A previous 24‐week randomised trial demonstrated that sulfasalazine (SSZ) treatment was superior to placebo (PLAC) in suppressing disease activity in patients with oligo‐ and polyarticular onset juvenile idiopathic arthritis (JIA). The current study determines the long‐term outcome of th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van Rossum, Marion A J, van Soesbergen, Renée M, Boers, Maarten, Zwinderman, Aeilko H, Fiselier, Theo J W, Franssen, Marcel J A M, Cate, Rebecca ten, van Suijlekom‐Smit, Lisette W A, Wulffraat, Nico M, van Luijk, Wilma H J, Oostveen, Johanna C M, Kuis, Wietse, Dijkmans, Ben A C
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2007
Assuntos:
Extended Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2111611/
https://ncbi.nlm.nih.gov/pubmed/17491099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.064717
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados